Clincosm LogoSign in Get a demo

recurrent cancer

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)

Not yet recruiting
  • Head and Neck Cancer
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Oct 24, 2023

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

Not yet recruiting
  • Refractory Cancer
  • +3 more
  • IMA402 (Phase Ia)
  • +2 more
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +12 more
Jul 14, 2023

Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)

Not yet recruiting
  • Recurrent Cancer
  • +2 more
  • Lyon, France
    Centre Léon Bérard
May 12, 2023

Pattern & Outcomes of Advanced, Recurrent or Metastatic

Completed
  • Oncology
  • +4 more
  • Argenteuil, France
  • +29 more
Jan 23, 2023

Recurrence After Whipple's (RAW) Study

Active, not recruiting
  • Pancreatic Cancer
  • +13 more
  • Pancreaticoduodenectomy
  • Clayton, Victoria, Australia
  • +28 more
Jan 13, 2023

Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA401 (Phase Ia), IMA401 (Phase Ib))

Recruiting
  • Refractory Cancer
  • +3 more
  • IMA401 (Phase Ia)
  • IMA401 (Phase Ib)
  • Tübingen, Baden-Wurttemberg, Germany
  • +16 more
Dec 19, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Nasopharyngeal Carcinoma, Recurrent Cancer Trial in Guangzhou (Tranilast)

Recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Nov 15, 2022

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Colorectal Cancer, Quality of Life, Recurrent Cancer Trial (Lidocaine HCl 2% for injection, 0.9% sterile Sodium Chloride

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Lidocaine hydrochloride 2% for injection
  • 0.9% sterile Sodium Chloride solution for injection
  • (no location specified)
Aug 4, 2022

Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Jinan (CEA CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +5 more
  • CEA CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jul 19, 2022

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Completed
  • Liver Transplant Disorder
  • +2 more
  • Liver transplantation
  • Rome, RM, Italy
    Quirino Lai
Jun 27, 2022

Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Hangzhou (CEA CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +5 more
  • CEA CAR-T cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
May 30, 2022

SBRT in Reirradiation for Ultra-central Thoracic Malignant

Recruiting
  • Stereotactic Body Radiation Therapy
  • +3 more
  • stereotacitic body radiation therapy
  • Beijing, Beijing, China
    Peking University Third Hospital
May 31, 2022

Recurrent Cancer, Previous Radiation Trial (Radiation by protontherapy associated to nanoparticles injection)

Not yet recruiting
  • Recurrent Cancer
  • Previous Radiation
  • Radiation by protontherapy associated to nanoparticles injection
  • (no location specified)
Apr 19, 2022

Human Leukocyte Antigen Typing and Tumor Antigen Expression

Recruiting
  • Refractory Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Feb 14, 2022

    Salivary Gland Carcinoma, Metastatic Cancer, Recurrent Cancer Trial in France (Nivolumab)

    Completed
    • Salivary Gland Carcinoma
    • +2 more
    • Bordeaux, France
    • +10 more
    Jan 10, 2022

    End of Life Care, Advanced Cancer, Recurrent Cancer Trial in Tokyo (Mobile-based empathic communication support program to

    Recruiting
    • End of Life Care
    • +2 more
    • Mobile-based empathic communication support program to promote ACP discussion
    • Tokyo, Chuo-ku, Japan
      National Cancer Center Hospital, National Cancer Center
    Sep 26, 2021

    Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)

    Recruiting
    • Metastasis
    • +2 more
    • Stanford, California
    • +1 more
    Sep 27, 2021

    Ovarian Cancer, Recurrent Cancer Trial (CYH33)

    Not yet recruiting
    • Ovarian Cancer
    • Recurrent Cancer
    • (no location specified)
    Sep 5, 2021

    Recurrent Cancer, Prostate Cancer, Cervical Cancer Trial in Berlin (loco-regional hyperthermia)

    Recruiting
    • Recurrent Cancer
    • +9 more
    • loco-regional hyperthermia
    • Berlin, Germany
      Klinik für Radioonkologie und Strahlentherapie
    May 12, 2021

    Hepatocellular Carcinoma, Recurrent Cancer, Liver Transplant Trial in Toronto (Cabozantinib)

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2021

    Postoperative Complication After Free Flap Reconstruction for

    Completed
    • Head and Neck Cancer
    • +2 more
    • Reconstruction group
    • Recurrent group
    • Kaohsiung, Taiwan
      Kaohsiung Chang Gung Memorial Hospital
    Mar 26, 2020

    Recurrent Cancer Trial (SBRT, systemic therapy (chemo, hormon therapy, target therapy etc), palliative RT)

    Unknown status
    • Recurrent Cancer
    • SBRT
    • +2 more
    • (no location specified)
    Mar 2, 2016